v3.26.3
EQUITY TRANSACTIONS
 3 Months Ended
Jul. 31, 2026
Equity [Abstract]  
EQUITY TRANSACTIONS

NOTE E – EQUITY TRANSACTIONS

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $1.00 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value.

 

Common Stock

 

The Company is authorized to issue 750,000,000 shares of common stock, $0.001 par value. The Company had 54,636,926 and 53,602,365 shares of common stock issued and outstanding as of July 31, 2026, and April 30, 2026, respectively. The Company had 35,334,706 and 34,028,221 shares of common classified as to be issued at July 31, 2026, and April 30, 2026, respectively.

 

During the three months ended July 31, 2026, the Company

 

  ● Issued 559,561 shares and 539,001 shares to be issued valued at $60,000 to accredited investors related to equity investments which includes 549,282 warrants at fair value of $15,710.
  ● Issued 400,000 shares and 100,000 shares to be issued valued at $46,000 for consulting services.
  ● Issued 75,000 shares of common stock valued at $12,500 upon the conversion of 25,000 shares of preferred series C shares.

 

During the three months ended July 31, 2025, the Company:

 

  ● Issued 781,986 shares and 538,424 shares to be issued valued at $95,000 to accredited investors related to equity investments which includes 660,205 warrants at fair value of $25,869
  ● Issued 450,000 shares valued at $54,435 for consulting services
  ● Issued 136,809 shares of common stock valued at $19,985 upon the settlement of liability
  ● 50,000 shares of common stock to be issued valued at $4,000 to accredited investors relating to promissory notes

 

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $1 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value.

 

During the three months ended July 31, 2026, and 2025, the Company did not issue any preferred stock.

 

During the quarter ended July 31, 2026, the Company

 

  ● Converted 25,000 Series C preferred shares to 75,000 shares of common stock

 

During the year ended April 30, 2026, the Company

 

  ● Converted 5,260 Series D preferred shares to 21,040 shares of common stock

 

As of July 31, 2026, and April 30, 2026, the Company had:

 

   July 31,   April 30, 
Preferred stock outstanding shares  2026   2026 
Series A   125    125 
Series B   -    - 
Series C   1,928,157    1,953,157 
Series D   768,288    768,288